Toggle search
Toggle menu
413
21
41
7.1K
Pharmacopedia
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Main public logs

More actions
Pharmacopedia
BrowseCategoriesLog in
Pharmacopedia is being built in public. Pages may be incomplete.About this site

Combined display of all available logs of Pharmacopedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

Logs
(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)
  • 03:40, 20 May 2026 MDElliottMD talk contribs created page ASRS (Redirect to Adult ADHD Self-Report Scale) Tag: New redirect
  • 03:26, 20 May 2026 MDElliottMD talk contribs created page Adult ADHD Self-Report Scale (Create encyclopedic page for the ASRS-v1.1 (Adult ADHD Self-Report Scale): development under the WHO (Kessler, Harvard; Adler, NYU), structure (18-item checklist + 6-item Screener), threshold scoring, validation, the DSM-5 update, wiki use as the validated companion to AMAAS, and the NYU/Harvard licensing + mandatory attribution notice. Citations Kessler 2005 PMID 15841682, Kessler 2007 PMID 17623385, Ustun 2017 PMID 28384801, all NCBI-eutils-verified. Describes the instrument; reproduces no...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Category:Pharmacogenomic phenotypes (Create Category:Pharmacogenomic phenotypes per the canonical category-page spec: descriptive history-first lead (the debrisoquine polymorphism, Smith at St Mary's London 1977, Mahgoub 1977 PMID 71400, origin of the poor/extensive metabolizer vocabulary; Weinshilboum 1980 TPMT PMID 7191632; the genotype-to-phenotype harmonisation Caudle 2020 PMID 31647186). Phenotypes-indexed list grouped by gene (26 pages). Notes on scope, About-these-pages, references. Carries Category:Pharmacogenomics paren...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype NUDT15 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype NUDT15 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype NUDT15 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype TPMT normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype TPMT intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype TPMT poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype UGT1A1 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype UGT1A1 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype UGT1A1 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 ultrarapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 rapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C9 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C9 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C9 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 ultrarapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 rapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2D6 ultrarapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2D6 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2D6 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
  • 23:28, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2D6 poor metabolizer (Sandbox-save CYP2D6 poor metabolizer phenotype page as the template exemplar for the pharmacogenomic phenotype subpage set (26 pages across 7 enzymes with CPIC phenotype schemes). Definitional satellite page of Enzyme:CYP2D6: lead defines the phenotype + the two-directional clinical principle (activation case vs clearance case); sections for genotype basis, population frequency, clinical consequences, phenocopying. CPIC opioid guideline cited PMID 33387367 (verified). Deliberate deviation fro...)
  • 23:27, 19 May 2026 MDElliottMD talk contribs created page Category:CuratedCategoryPage (Create CuratedCategoryPage maintenance marker (hidden category) per canonical category-page structure)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Category:Drug-metabolizing enzymes (Create Category:Drug-metabolizing enzymes: curated index of the 11 enzyme entity pages (8 CYPs + UGT1A1 + TPMT + NUDT15) at their canonical Pharmacopedia: sandbox location, grouped by enzyme family, with scope notes distinguishing enzymes from transporters and non-enzyme variant loci. Parent Category:Pharmacogenomics.)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Enzyme NUDT15 (Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Enzyme TPMT (Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Enzyme UGT1A1 (Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Enzyme CYP2E1 (Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Enzyme CYP2C9 (Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Enzyme CYP2C8 (Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Enzyme CYP2B6 (Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...)
  • 22:39, 19 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Enzyme CYP1A2 (Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...)
  • 22:11, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/CYP2B6 (Sandbox-save CYP2B6 enzyme entity page (9th pharmacogenomics enzyme page). History-first spine: the rehabilitation of a long-neglected enzyme - Lang/Klein/Zanger Dr. Margarete Fischer-Bosch Institute Stuttgart 2001 polymorphism survey PMID 11470993. 16-row collapsible-sortable substrate table (efavirenz canonical, bupropion probe, methadone, cyclophosphamide/ifosfamide bioactivation, ketamine, others). Full PM/IM/NM/RM/UM phenotype classification per CPIC efavirenz guideline. Major variant *6...)
  • 22:03, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/CYP1A2 (Sandbox-save CYP1A2 enzyme entity page (8th pharmacogenomics enzyme page). History-first spine: Anthony Conney enzyme-induction research (Hoffmann-La Roche, Nutley NJ), 1982 Clowes Memorial Lecture PMID 6814745, AhR induction mechanism. 28-row collapsible-sortable substrate table (clozapine/olanzapine/theophylline/tizanidine headline substrates; caffeine probe; antidepressants, triptans, others). Phenotype section: honest no-PM/IM/NM-bedside-classification (like CYP3A4); variability dominated...)
  • 21:44, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/NUDT15 (Sandbox-save NUDT15 enzyme entity page (7th pharmacogenomics enzyme page, parallel to TPMT). History-first spine: Asan Medical Center Seoul 2014 GWAS in Korean IBD cohort discovering NUDT15 rs116855232 Arg139Cys, Yang 2014 Nat Genet PMID 25108385; Moriyama 2016 Nat Genet mechanism (St. Jude) PMID 26878724; Yang 2015 JCO ALL extension PMID 25624441; Moriyama 2017 Blood diverse-ancestry alleles PMID 28659275; Relling 2019 CPIC TPMT+NUDT15 PMID 30447069; PharmGKB Whirl-Carrillo 2021 PMID 3421602...)
  • 21:35, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/TPMT (Sandbox-save TPMT enzyme entity page (6th pharmacogenomics enzyme page). History-first spine: Weinshilboum & Sladek 1980 Mayo Clinic bimodal-distribution discovery PMID 7191632, one of the foundational pharmacogenetics demonstrations. Lennard 1989 azathioprine-toxicity link PMID 2758725; Krynetski 1995 PNAS TPMT*2 molecular variant PMID 7862671; Loennechen 1998 TPMT*3C PMID 9695718; Relling 2019 CPIC TPMT+NUDT15 thiopurine dosing PMID 30447069. NUDT15 cross-reference section cites Yang 2014 N...)
  • 21:09, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/UGT1A1 (Sandbox-save UGT1A1 enzyme entity page (5th of 10 pharmacogenomics enzyme pages). History-first spine: Gilbert 1901 Paris + Bosma 1995 NEJM Amsterdam closure (UGT1A1*28 promoter TA-repeat discovery). Two CPIC/DPWG guidelines cited: Gammal 2016 CPIC atazanavir PMID 26417955, Hulshof 2023 DPWG irinotecan PMID 36443464. Plus mechanistic refs Iyer 1998 JCI PMID 9466980 (UGT1A1 + SN-38), Innocenti 2004 JCO PMID 15007088 (irinotecan + UGT1A1*28 + neutropenia). Plus Tukey & Strassburg 2000 Annu Rev...)
  • 20:44, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/CYP2C19 (Retrofit CYP2C19 sandbox per Mark 2026-05-19 Option C decision: collapsible-sortable near-complete substrate table (32 rows: PPIs, SSRIs, clopidogrel/proguanil activation, voriconazole, diazepam, mephenytoin probe, carisoprodol, others; tier-tagged major/moderate/minor/partial; activation reactions flagged for clopidogrel and proguanil). Plus Comprehensive substrate and interaction tables pointer section. NOTE: also restored three CPIC-guideline ref definitions (cpic-clopidogrel-2022 PMID 350...)
  • 20:44, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/CYP3A4 (Retrofit CYP3A4 sandbox per Mark 2026-05-19 Option C decision: collapsible-sortable near-complete substrate table (57 rows: benzodiazepines, calcium channel blockers, statins, immunosuppressants, anti-cancer, macrolides, HIV protease inhibitors, DOACs, opioids, antifungals, PDE5 inhibitors, antihistamines, endogenous steroids, others; tier-tagged major/moderate/minor/partial). Plus Comprehensive substrate and interaction tables pointer section naming Flockhart Indiana University, FDA Drug Dev...)
  • 20:44, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/CYP2D6 (Retrofit CYP2D6 sandbox per Mark 2026-05-19 Option C decision: collapsible-sortable near-complete substrate table (49 rows: opioid prodrugs, TCAs, SSRIs/SNRIs, antipsychotics, beta blockers, antiarrhythmics, antiemetics, tamoxifen, atomoxetine, perhexiline, antihistamines, others; tier-tagged major/moderate/minor/partial; activation reactions flagged for codeine/tramadol/risperidone/tamoxifen/venlafaxine). Plus Comprehensive substrate and interaction tables pointer section naming Flockhart In...)
  • 19:31, 19 May 2026 MDElliottMD talk contribs created page User:MDElliottMD/Sandbox/CYP2C9 (Sandbox-save CYP2C9 enzyme entity page (4th of 10 pharmacogenomics enzyme pages). History-first spine: Rettie 1992 Seattle / S-warfarin / CYP2C9. Three CPIC guidelines cited: warfarin 2017 PMID 28198005, phenytoin 2020 PMID 32779747, NSAIDs 2020 PMID 32189324. Plus Rettie 1992 PMID 1581537, Sullivan-Klose 1996 PMID 8873220 (CYP2C9*3 / tolbutamide), Aithal 1999 PMID 10073515 (Lancet warfarin dose / bleeding). All 6 PMIDs NCBI-eutils-verified. Final home Enzyme:CYP2C9 once namespace registered.)
  • 19:20, 19 May 2026 MDElliottMD talk contribs created page Category:Plant (Revise Category:Plant root page per interface-claude 2026-05-20 spec: (A) split 10 -> 13 subcategories (Psychedelic / Entheogenic split; Sedative (botanical) / Anxiolytic (botanical) split; Toxic plants / Historical plants split); (B) Functional mushrooms renamed to Medicinal mushroom per ethnomycology convention; (C) Pendell axis section locked with full 11-class wikitable and volume display labels (Inebriant/Stimulant/Visionary); (D) adaptogen EMA HMPC 2008 Reflection Paper EMEA/HMPC/102655...)
  • 19:20, 19 May 2026 MDElliottMD talk contribs created page Category:Pharmaceutical (Revise Category:Pharmaceutical root page per interface-claude 2026-05-20 spec: (A) inline citations added to History section (Huxtable 2001 PMID 14993340 for Sertürner morphine; Sneader 2005 book for Pelletier-Caventou alkaloid sweep, Mein atropine, Niemann cocaine, Bayer barbital; Sneader 2000 BMJ PMID 11124191 for aspirin; Gensini 2007 J Infect PMID 16567000 for Ehrlich/Salvarsan); (B) expanded class subcategories list grouped by therapeutic domain with explicit to-be-created flags for Anti...)
(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)
Retrieved from "https://pharmacopedia.wiki/p/Special:Log/MDElliottMD"